Evidence map›Paper›PMID 29672979›Full record

ArticlePhytotherapy research : PTR2018

Interaction of ascaridole, carvacrol, and caryophyllene oxide from essential oil of Chenopodium ambrosioides L. with mitochondria in Leishmania and other eukaryotes.

Lianet Monzote, Gerald Geroldinger, Matthias Tonner, Ramón Scull, Sritama De Sarkar, Sophie Bergmann, Markus Bacher, Katrin Staniek, Mitali Chatterjee, Thomas Rosenau and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Phytotherapy research : PTR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Antiamoeba and Antitrypanosoma Activity of the MexicanPathogens (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Essential Oils and Extracts from Epazote (Plants (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Promising Antileishmanial Activity ofMolecules (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Essential oils fromFrontiers in pharmacology · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Lianet MonzoteInstitute of Pharmacology and Toxicology, Department of Biomedical Sciences, University of Veterinary Medicine Vienna, Vienna, Austria.
Gerald GeroldingerInstitute of Pharmacology and Toxicology, Department of Biomedical Sciences, University of Veterinary Medicine Vienna, Vienna, Austria.
Matthias TonnerInstitute of Pharmacology and Toxicology, Department of Biomedical Sciences, University of Veterinary Medicine Vienna, Vienna, Austria.
Ramón ScullDepartment of Chemistry, Institute of Pharmacy and Food, Havana University, Havana, Cuba.
Sritama De SarkarDepartment of Pharmacology, Institute of Postgraduate Medical Education & Research, Kolkata, India.
Sophie BergmannInstitute of Pharmacology and Toxicology, Department of Biomedical Sciences, University of Veterinary Medicine Vienna, Vienna, Austria.
Markus BacherDepartment of Chemistry, Division of Chemistry of Renewables, University of Natural Resources and Life Sciences, Tulln, Austria.
Katrin StaniekInstitute of Pharmacology and Toxicology, Department of Biomedical Sciences, University of Veterinary Medicine Vienna, Vienna, Austria.
Mitali ChatterjeeDepartment of Pharmacology, Institute of Postgraduate Medical Education & Research, Kolkata, India.
Thomas RosenauDepartment of Chemistry, Division of Chemistry of Renewables, University of Natural Resources and Life Sciences, Tulln, Austria.
Lars GilleInstitute of Pharmacology and Toxicology, Department of Biomedical Sciences, University of Veterinary Medicine Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-1223-0201
University of Veterinary Medicine Vienna · ATBOKU University · ATUniversity of Havana · CU

Funding

Austrian Exchange Service (OEAD) IN 04/2017Austrian Science Fund (FWF) P 27814-B22Austrian Science Fund FWF P 27814
6 · The paper itself

Abstract

The antileishmanial activity of the essential oil (EO) from Chenopodium ambrosioides L. has been demonstrated in vitro and in animal models, attributed to the major components of the EO. This study focused on the effects of the three major EO compounds carvacrol, caryophyllene oxide (Caryo), and the antileishmanial endoperoxide ascaridole (Asc) on mitochondrial functions in Leishmania tarentolae promastigotes (LtP). EO and Caryo were able to partially inhibit the leishmanial electron transport chain, whereas other components failed to demonstrate a direct immediate effect. Caryo demonstrated inhibition of complex III activity in LtP and in isolated complex III from other species. The formation of superoxide radicals was studied in Leishmania by electron spin resonance spectroscopy in the presence of iron chelators wherein selected compounds failed to trigger a significant immediate additional superoxide production in LtP. However, upon prolonged incubation of Leishmania with Asc and especially in the absence of iron chelators (allowing the activation of Asc), an increased superoxide radical production and significant impairment of mitochondrial coupling in Leishmania was observed. Prolonged incubation with all EO components resulted in thiol depletion. Taken together, the major components of EO mediate their leishmanicidal activity via different mitochondrial targets and time profiles. Further studies are required to elucidate possible synergistic effects of carvacrol and Asc and the influence of minor compounds.

Indexed as

AnimalsAntiprotozoal AgentsCattleChenopodium ambrosioidesCyclohexane MonoterpenesCymenesLeishmaniaMitochondriaMonoterpenesOils, VolatilePeroxidesPolycyclic SesquiterpenesSaccharomyces cerevisiaeSesquiterpenesSuperoxidesAntiprotozoal Agentsascaridolecarvacrolcaryophyllene oxideCyclohexane MonoterpenesCymenesMonoterpenesOils, VolatilePeroxidesPolycyclic SesquiterpenesSesquiterpenesSuperoxidesascaridolecarvacrolcaryophyllene oxideChenopodium ambrosioides LLeishmaniamitochondria

Identifiers

PMID29672979
PMCPMC6208284
OpenAlexW2802797575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.